|
Class 2 Device Recall ACCELERATOR Automated Processing System |
![see related information](../images/related-info.gif) |
Date Initiated by Firm |
October 27, 2008 |
Date Posted |
September 18, 2009 |
Recall Status1 |
Terminated 3 on December 02, 2009 |
Recall Number |
Z-2221-2009 |
Recall Event ID |
50488 |
Product Classification |
Calculator/data processing module, for clinical use - Product Code JQP
|
Product |
ACCELERATOR APS System Input/Output Module (IOM); List Number: 7L01-01; manufactured by Inpecco SpA, Segrate (MI), Italy.
|
Code Information |
Serial Numbers: ABT 042, ABT 055, ABT 037, ABT 016, ABT 041, ABT 046, ABT 035, ABT 040, ABT 039, ABT 033, ABT 028, ABT 011, ABT 006 and ABT 007. |
Recalling Firm/ Manufacturer |
Abbott Laboratories, Inc 1921 Hurd Drive PO Box 152020 Irving TX 75038-4313
|
For Additional Information Contact |
972-518-6000
|
Manufacturer Reason for Recall |
When an ARCHITECT c16000 System is connected to an ACCELERATOR APS System, the software on the ACCELERATOR APS System may not generate an error warning when a Sample Presentation/Sample Queue error occurs, which could result in contamination of subsequent samples.
|
FDA Determined Cause 2 |
Software design |
Action |
Abbott Laboratories notified Customers of the affected device via a "Product Correction" letter dated October 27, 2008. Consignees provided with a temporary work around until a service representative upgrades the system software.
For further information, contact your local Abbott Laboratories, Inc. service representative. |
Quantity in Commerce |
15 units |
Distribution |
International Distribution -- Spain, Italy, the United Kingdom, Sweden, Switzerland, the Netherlands, France, Canada and Scotland. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|